"Lactobacillus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Pathogenicity from this genus is rare.
| Descriptor ID |
D007778
|
| MeSH Number(s) |
B03.353.750.450.475 B03.510.460.400.410.475.475 B03.510.550.450.475
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lactobacillus".
Below are MeSH descriptors whose meaning is more specific than "Lactobacillus".
This graph shows the total number of publications written about "Lactobacillus" by people in this website by year, and whether "Lactobacillus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2017 | 6 | 9 | 15 |
| 2018 | 11 | 7 | 18 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lactobacillus" by people in Profiles.
-
Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains. Biomed Res Int. 2021; 2021:6662027.
-
Is nutraceutical supplementation appropriate for COVID-19 management? Allergy Asthma Proc. 2021 05 01; 42(3):e103-e105.
-
Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials. Expert Rev Respir Med. 2021 06; 15(6):805-821.
-
Probiotics: A potential immunomodulator in COVID-19 infection management. Nutr Res. 2021 03; 87:1-12.
-
Lacticaseibacillus paracasei DG enhances the lactoferrin anti-SARS-CoV-2 response in Caco-2 cells. Gut Microbes. 2021 Jan-Dec; 13(1):1961970.
-
Respiratory syndrome coronavirus-2 response: Microbiota as lactobacilli could make the difference. J Med Virol. 2021 06; 93(6):3288-3293.
-
Nutraceuticals as immune-stimulating therapy to fight COVID-19. Combination of elements to improve the efficacy. Eur Rev Med Pharmacol Sci. 2020 Sep; 24(17):9182-9187.
-
Identification of Key Aroma Compounds in Type I Sourdough-Based Chinese Steamed Bread: Application of Untargeted Metabolomics Analysisp. Int J Mol Sci. 2019 Feb 14; 20(4).
-
Spatial variations in intestinal skatole production and microbial composition in broilers. Anim Sci J. 2019 Mar; 90(3):412-422.
-
Comparative analysis of the gut microbiota in distinct statin response patients in East China. J Microbiol. 2018 Dec; 56(12):886-892.